期刊文献+

慢性肾衰继发甲状旁腺功能亢进的手术治疗

Surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure
原文传递
导出
摘要 继发性甲状旁腺功能亢进(SHPT)作为慢性肾功能衰竭的常见并发症,其治疗方法一直是甲状旁腺临床治疗研究的重点。SHPT发病机制是由于慢性肾病进展至终末期后,人体内环境的改变导致甲状旁腺激素异常分泌,造成包括钙、磷等离子的分泌及代谢紊乱,从而引起包括泌尿系统、骨骼系统、心血管系统在内的乃至全身各个系统的功能紊乱的严重并发症。本文就慢性肾功能衰竭SHPT的国内外手术治疗现状进行综述,以增加外科医生对其手术治疗的认识,从而给予患者更合适的手术治疗方案指导,改善慢性肾衰SHPT患者的生活质量。 Secondary hyperparathyroidism(SHPT),as a common complication of chronic renal failure,has always been a focus of clinical research on the treatment of parathyroidism.The pathogenesis of SHPT is due to the abnormal secretion of parathyroid hormone caused by changes in the internal environment of the human body after the progression of chronic kidney disease to the end stage,resulting in the secretion and metabolic disorders of calcium and phosphorus plasma,leading to serious complications of functional disorders in various systems including the urinary system,skeletal system,cardiovascular system,and even the whole body.This article reviews the current status of surgical treatment of SHPT in patients with chronic kidney disease at home and abroad,in order to increase surgeons'understanding of surgical treatment,so as to provide patients with better surgical treatment program guidance and improve the quality of life of patients with SHPT.
作者 麻紫月 张翊伦 MA Ziyue;ZHANG Yilun(Clinical Medical School,Guizhou Medical University,Guiyang,Guizhou 550001,China;不详)
出处 《中国临床研究》 CAS 2024年第6期946-949,共4页 Chinese Journal of Clinical Research
关键词 慢性肾功能衰竭 继发性甲状旁腺功能亢进 甲状旁腺切除术 机器人辅助技术 介入治疗 Chronic renal failure Secondary hyperparathyroidism Parathyroidectomy Robot-assisted technology Interventional therapy
  • 相关文献

参考文献7

二级参考文献64

  • 1杨瑞,王淑君,张颖.亚甲蓝作为淋巴示踪剂的研究与展望[J].中国药剂学杂志(网络版),2009(2):65-71. 被引量:16
  • 2Yang F, Jin C, Yang D, et al. Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treat- ment [J]. Eur J Cancer, 2011, 47(12): 1873-1882.
  • 3Khairy GA, A1-SaifA. Incidental parathyroidectomy during thyroid resection: incidence, risk factors, and outcome [J]. Ann Saudi Med, 2011, 31(3): 274-278.
  • 4Shen WT, Ogawa L, Ruan D, et al. Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations [J]. Arch Surg, 2010, 145(3): 272-275.
  • 5Moo TA, McGill J, Allendorf J, et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma [J]. World J Surg, 2010, 34(6): 1187-1191.
  • 6Catarci M, Zaraca F, Angeloni R, et al. Preoperative lymphos- cintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. Apilot study [J]. J Surg Oncol, 2001, 77(1): 21-24.
  • 7Haigh PI, Giuliano AE. Sentinel lymph node dissection for thyroid malignancy [J]. Recent Results Cancer Res, 2000, 157(12): 201-205.
  • 8Ji YB, Lee K J, Park YS, et al. Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma [Jl. Ann Surg Oncol, 2012, 19(6): 1868-1873.
  • 9袁孝军,徐兆强,蔡崇贵.^(99m)Tc-MIBI显像及CT对原发性甲状旁腺机能亢进症的诊断价值[J].医学影像学杂志,2007,17(11):1155-1157. 被引量:9
  • 10柳卫,徐兆强,胡建民,常国钧,姚薇萱,李永军,陈建伟.继发性甲状旁腺功能亢进的^(99)Tc^m-MIBI双时相显像[J].中华核医学杂志,1999,19(1):29-30. 被引量:10

共引文献213

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部